Source: DEAL FEED INTERNATIONAL

AtheroMed: Volcano Corporation acquisition of AtheroMed Inc

SAN DIEGO, May 27, 2014 — Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today it has signed an agreement to acquire AtheroMed, Inc., a privately-held company that has developed the Phoenix® Atherectomy System used […]The post Volcano Corporation acquisition of AtheroMed Inc appeared first on Deal Feed International.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Michael T. MacKinnon's photo - President & CEO of AtheroMed

President & CEO

Michael T. MacKinnon

CEO Approval Rating

70/100

Read more